Sees FY25 cash burn $60M-$70M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADPT:
- Adaptive Biotechnologies reports Q4 EPS (23c), consensus (24c)
- Adaptive Biotechnologies (ADPT) Q4 Earnings Cheat Sheet
- Adaptive, NeoGenomics partner to expand access to disease monitoring
- Adaptive Biotechnologies announces lab fee schedule rate of $2,007 for clonoSEQ
- Adaptive Biotechnologies price target raised to $9 from $8 at BTIG